Is Taurine A Biomarker?

Advances in Clinical Chemistry

Volumn 41, Issue , 2006, Pages 1-21

  Schuller Levis, Georgia ^a   Park, Eunkyue ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646173214     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(05)41001-X     Document Type: Review

References (83)

1. Huxtable R. The physiological actions of taurine. Physiol Rev 72 (1992) 101-163
2. Sturman J. Taurine in development. Physiol Rev 73 (1993) 119-146
3. Fudaka K., Hirai Y., Yoshida H., Hakajima T., and Ussi T. Free amino acid content of lymphocytes and granulocytes compared. Clin Chem 28 (1982) 1758-1761
4. Sturman J. Taurine in infant physiology and nutrition. Pediat Nutr Rev (1986) 1-11
5. Bella D., Hirchberger L., Kwon Y., and Stipanuk M. Cysteine metabolism in periportal and perivenous hepatocytes: Perivenous cells have greater capacity for glutathione production and taurine synthesis but not for cysteine catabolism. Amino Acids 23 (2002) 453-458
6. Hayes K., Rabin A., and Berson E. An ultrastructural study of nutritionally induced and reversed retinal degeneration in cats. Am J Pathol 78 (1975) 505-524
7. Gaull G., Rassin D., Raiha N., and Heinonen K. Milk protein quantity and quality in low-birth-weight infants. III. Effects on sulfur amino acids in plasma and urine. J Pediatr 90 (1977) 348-355
8. Aerts L., and Van Assche F. Taurine and taurine-deficiency in the perinatal period. J Perinat Med 30 4 (2002) 281-286
9. Wharton B., Morley R., Isaaca E., Cole T., and Lucas A. Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed 89 6 (2004 November) F97-F98
10. Cho K., Kim E., and Chen J. Taurine intake and excretion in patients undergoing long term enteral nutrition. In: Schaffer, et al. (Ed). Taurine 3: Cellular and Regulatory Mechanisms (1998), Plenum Press, New York 605-612
11. Lourence R., and Camilo M. Taurine: A conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 17 6 (2002) 262-270
12. Zmora E., Gorodischer R., and Bar-Ziv J. Multiple nutritional deficiencies in infants from a strict vegetarian community. Am J Dis Child 133 (1979) 141-144
13. Shinwell E., and Gorodischer R. Totally vegetarian diets and infant nutrition. Pediatrics 70 (1982) 582-586
14. Tyson J., Lasky R., Flood D., Mize T., Picone T., and Paule C. Randomized trial of taurine supplementation for infants <1300-gram birth weight: Effect on auditory brain stem evoked response. Pediatrics 83 (1989) 406-415
15. Schaffer S., Lombardini J., and Azuma J. Interaction between the action of taurine and angiotensin II. Amino Acids 18 (2000) 305-318
16. Schaffer S., Solodushko V., Pastukh V., Ricci C., and Azuma J. Possible cause of taurine-deficient cardiomyopathy: Potentiation of angiotensin II action. J Cadiovasc Pharmacol 41 (2003) 751-759
17. Militante J., and Lombardini J. Treatment of hypertension with oral taurine: Experimental and clinical studies. Amino Acids 23 (2002) 381-393
18. Fujita T., Ando K., Noda H., Ito Y., and Sato Y. Effects of increased adrenomedullary activity and taurine in young patient with borderline hypertension. Circulation 75 (1987) 525-532
19. Kohashi N., Okabayashi T., Hama J., and Katori R. Decreased urinary taurine in essential hypertension. Prog Clin Biol Res 125 (1983) 73-87
20. Yamori Y., Nara Y., Ikeda K., and Mizushima S. Is taurine a preventive nutritional factor of cardiovasucular diseases or just a biological marker of nutrition?. Adv Exp Med Biol 403 (1996) 623-629
21. Nonaka H., Tsujino T., Watari Y., Emoto N., and Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: Amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 104 (2001) 1165-1170
22. Park E., Quinn M., Wright C., and Schuller-Levis G. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor factor in activated RAW 264.7 cells. J Leuk Biol 54 (1993) 119-124
23. Pion P., Kittleson M., Thomas W., Skiles M., and Rogers Q. Clinical findings in cats with dilated cardiomyopathy and relationship of findings to taurine deficiency. J Am Vet Med Assoc 201 2 (1992) 267-274
24. Pion P., Kittleson M., Thomas W., Delellis L., and Roger Q. Response of cats with dilated cardiomyopathy to taurine supplementation. J Am Vet Med Assoc 201 2 (1992) 275-284
25. Lu P., Schuller-Levis G., and Sturman J. Distribution of taurine-like immunoreactivity in cerebellum of kittens from taurine-supplemented and taurine deficient mothers. Int J Dev Neurosci 9 (1991) 621-629
26. El Idrissi A., and Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19 (1999) 9459-9468
27. Idrissi A., and Trenkner E. Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29 (2004) 189-197
28. Kuriyama K., and Hashimoto T. Interrelationship between taurine and GABA. In: Schaffer S., Lombardini J., and Huxatable R. (Eds). Taurine 3: Cellular and Regulatory Mechanism (1998), Plenum Press, New York 329-337
29. Saransaari P., and Oja S. Modulation of taurine release by metabotropic receptors in the developing hippocampus. In: Della Corte L., Huxable R., Sgaragli G., and Tipton K. (Eds). Taurine 4: Taurine and Excitable Tissues (2000), Plenum Press, New York 257-264
30. Del Olmo M., Galarreta M., Bustamante J., MartindelRio R., and Solis J. Taurine-induced synaptic potentiation: Role of calcium and interaction with LRP. Neuropharmacology 391 (2000) 40-54
31. Chesney R., Helms R., Christensen M., Budreau A., Han X., and Sturman J. The role of taurine in infant nutrition. In: Schaffer S., Lombardini J., and Huxtable R. (Eds). Taurine 3: Cellular and Regulatory Mechanisms (1998), Plenum Press, New York 463-486
32. Uchida S., Nakanishi T., Kwon H., Preston A., and Handler J. Taurine behaves as an osmolyte in Madin-Darby canine kidney cells. Protection by polarized, regulated transport of taurine. J Clin Invest 88 (1991) 656-662
33. Tuner R. β-Amino acid transport across the renal brush-border membrane is coupled to both Na and Cl. J Biol Chem 261 (1988) 16060-16066
34. Chesney R., Gusowski N., and Dabbagh S. Renal cortex taurine content regulates renal adaptive response to altered dietary intake of sulfur amino acid. J Clin Chem 76 (1985) 2213-2221
35. Tachtman H., Barbour J., Sturman J., and Finberg L. Taurine and osmoregulation: Taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration. Pediatr Res 23 (1988) 35-39
36. Bourque M., Oliet S., and Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 15 (1994) 231-274
37. Adrogue R., and Madias N. Hypernatremia. N Engl J Med 342 (2000) 1493-1499
38. Cserr H., DePasquale M., and Patlak C. Regulation of brain water and electrolytes during auto hyperosmolality in rats. Am J Physiol 253 (1987) F522-F529
39. Loyher M., Mutin M., Woo S., Kwon H., and Tappaz M. Transcription factor tonicity-responsive enhancer-binding protein (TonEBP) which transactivates osmoprotective genes is expressed and upregulated following acute systemic hypertonicity in neurons in brain. Neuroscience 124 1 (2004) 89-104
40. You J., and Chang K. Effects of taurine supplementation on lipid peroxidation, blood glucose and blood lipid metabolism in streptozotocin-induced diabetic rats. In: Schaffer S., Lombardini J., and Huxtable R. (Eds). Taurine 3 (1998), Plenum Press, New York 163-168
41. Chang K., and Kwon W. Immunohistochemical localization of insulin-pancreatic β-cells of taurine-supplemented or taurine-depleted rats. In: Della Corte L., Huxtable R., Sgaragli G., and Tipton K. (Eds) (2000), Plenum Press, New York 579-587
42. Nandhini A., Thirunavukkarasu V., Ravichandran M., and Anuradha C. Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. Singapore Med J 46 (2005) 82-87
43. Arany E., Strutt B., Romanus P., Remacle C., Reusens B., and Hill D. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice. Diabetologia 47 (2004) 1831-1837
44. Franconi F., Di Leo M., Bennardini F., and Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus. Neurochem Res 29 (2004) 143-150
45. Han J., Bae J., Kim S., et al. Taurine increases glucose sensitivity of UCP2-overexpressing between cells by ameliorating mitochondrial metabolism. Am J Physiol Endocrinol Metab 287 (2004) E1008-E1018
46. Gupta S., Pablo A., Jiang X., Wang N., Tall A., and Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99 (1997) 2752-2761
47. Chu N., Spiegelman D., Hotamisligil G., Refai N., Stampler M., and Remin I. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157 (2001) 495-503
48. Park E., Alberti J., Quinn M., and Schuller-Levis G. Taurine chloramine inhibits the production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. In: Schaffer S., Lombardini J., and Huxtable R. (Eds). Taurine 3: Cellular and Regulatory Mechanisms (1998), Plenum Press, New York 177-182
49. Nissen S., Tuzeu M., Schoehagan P., et al. Statin therapy, LDL cholesterol, C-reactive protein and coronary artery disease. N Engl J Med 352 (2005) 29-38
50. Ridker P., Cannon C., Morrow D., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
51. Facila L., Nunez J., Bertomeu G., et al. Early determinatrion of homocysteine levels in aute coronary syndromes, is it an independent prognostic factor. Int J Cardiol 100 (2005) 275-279
52. Hori R., Yamori Y., Nara Y., Sawamura M., and Mano M. Effects of sulfur amino acids on the development of hypertension and atherosclerosis in stroke-prone spontaneously hypertensive rats. J Hypertens 5 (1987) S223-S225
53. Murakami S., Yamagishi I., Asami Y., et al. Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52 5 (1996) 303-313
54. Murakami S., Kondo Y., Toda Y., et al. Effect of taurine on cholesterol metabolism in hamsters: Up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70 20 (2002) 2355-2366
55. Schuller-Levis G., Mehta P., Rudelli R., and Sturman J. Immunologic consequence of taurine deficiency in cats. J Leukoc Biol 47 (1990) 321-333
56. Gordon R., Heller R., and Heller R. Taurine protection of lungs in hamster models of oxidant injury. In: Lombardine J., Schaffer S., and Azuma J. (Eds). Taurine: Nutritional Value and Mechanisms of Action (1992), Plenum Press, New York 319-328
57. Wang Q., Giri S., Hyde D., and Li C. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol 42 (1991) 1115-1122
58. Schuller-Levis G., and Park E. Taurine: New implications for an old amino acid. FEMS Microbiol Lett 226 (2003) 195-202
59. Della Corte L., Crichton R., Duburs G., et al. The use of taurine analogues to investigate taurine functions and their potential therapeutic application. Amino Acids 23 (2002) 367-379
60. Cunningham C., Tipton K., and Dixon H. Conversion of taurine into N-chloramine (taurine Chloramine) and sulphoacetaldehyde in response to oxidative stress. Biochem J 330 (1998) 939-945
61. Olszowski S., Olszowska E., Kusio D., and Szneler E. Suphoacetaldehyde as a product of taurine chloramines peroxidation at site of inflammation. Amino Acids 22 (2002) 145-153
62. Cantin A. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro: Role of anion transport. J Clin Invest 93 (1994) 606-614
63. Peskin A., Midwinter R., Harwoood D., and Winterbourn C. Chlorine transfer between glycine, taurine, and histamine: Reaction rates and impact on cellular reactivity. Free Radic Biol Med 38 (2005) 397-405
64. Park E., Jia J., Quinn M., and Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 102 (2002) 179-184
65. Choray M., Kontny E., Marcinkiewicz J., and Maslinski W. Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 23 (2002) 407-413
66. Marcinkiewicz J., Grabowska A., Bereta J., and Stelmaszynska T. Taurine chloramine, a product of activated neutrophils inhibits in vitro the generation of nitric oxide and other macrophage inhibitory mediators. J Leukoc Biol 58 (1995) 667-674
67. Chorazy-Massalska M., Kontny E., Kornatka A., et al. The effect of taurine-chloramine on proinflammatory cytokine production by peripheral blood mononuclear cells isolated from rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 22 (2004) 692-698
68. Barua M., Liu Y., and Quinn M. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: Decreased NF-kβ activation and lkβ kinase activity. J Immunol 167 (2002) 2275-2281
69. Suzuki F., Suzuki T., Wada T., Saigo K., and Watanabe K. Taurine as a constituent of mitochondrial tRNA: New insights into the functions of taurine and human mitochondrial diseases. EMBO J 21 (2002) 6581-6589
70. Chung Y., Chung Wassif W., Bell J., Hurley M., and Scott D. Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis. Rheumatology 42 (2003) 298-303
71. Nakamura H., Kajikawa R., and Ubuka T. A study on the estimation of sulfur-containing amino acid metabolism by the determination of urinary sulfate and taurine. Amino Acid 23 (2002) 427-431
72. Waterfield C., Turton J., Scales M., and Timbrell J. Taurine, a possible urinary marker of liver damage: A study of taurine excretion in carbon tetrachloride-treated rats. Arch Toxicol 65 (1991) 548-555
73. Cataldi T., Telesca G., and Bianco G. Improved determination of taurine by high-performance anion-exchange chromatography with integrated pulsed amperometric detection (HPAEC-IPAD). Anal Bioanal Chem 378 (2004) 804-810
74. Agostoni C., Carratu B., Boniglia C., Riva E., and Sanzini E. Free amino acid content in standard infant formulas: Comparison with human milk. J Am Coll Nutr 19 (2000) 434-438
75. Beckonert O., Monnerjahn J., Bonk U., and Leibfritz D. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed 16 (2003) 1-11
76. Kondzeilla D., Qu H., Ludemann W., Brinker T., Sletvold O., and Sonnewald U. Astrocyte metabolism is disturbed in the early development of experimental hydrocephalus. J Neurochem 85 (2003) 274-281
77. De Micheli E., Alfieri A., Pinna G., et al. Extracellular levels of taurine in tumoral, peritumoral, and normal brain tissue in patients with malignant glioma: An Intraoperative Microdialysis Study. In: Della Corte L., Huxatable R., Sgaragli G., and Tipton K. (Eds). Taurine 4: Taurine and Excitable Tissues (2000), Plenum Press, New York 621-625
78. De Micheli E., Pinna G., Alfieri A., et al. Post-operative monitoring of cortical taurine in patients with subarachnoid hemorrhage: A microdialysis study. In: Schaffer S., Lombardini J., and Huxtable R. (Eds). Taurine 3: Cellular and Rregulatory Mechanisms (1998), Plenum Press, New York 209-218
79. Pelleymounter Jr. R., Dawson M., Cullen M., Gollub M., and Liu S. An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers. Brain Res Bull 48 (1999) 319-324
80. Csernansky J., Bardgett M., Sheline Y., Morris J., and Olney J. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology 46 (1996) 1715-1720
81. Molina J., Jimeney-Jimeney P., Gomaz C., et al. Decreased cerebrospinal fluid levels of insulin in patients with Alzheimer's disease. Acta Neurol Scand 106 (2002) 347-350
82. Nanobashvili J., Neumayer C., Fugl A., et al. Ischemia/reperfusion injury of skeletal muscle: Plasma taurine as a measure of tissue damage. Surgery 133 (2003) 91-100
83. Kingston R., Kelly C., and Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr Pharm Des 10 (2004) 2401-2410